| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,594 |
4,112 |
$559K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,046 |
938 |
$545K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,336 |
2,128 |
$431K |
| 80053 |
Comprehensive metabolic panel |
4,593 |
3,839 |
$158K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
480 |
426 |
$113K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
160 |
142 |
$106K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,701 |
2,195 |
$102K |
| 70450 |
Computed tomography, head or brain; without contrast material |
446 |
393 |
$99K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
116 |
86 |
$96K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
176 |
152 |
$85K |
| 71045 |
Radiologic examination, chest; single view |
2,466 |
2,214 |
$84K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,251 |
4,446 |
$78K |
| 84484 |
|
2,292 |
1,681 |
$75K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,247 |
1,123 |
$63K |
| 83735 |
|
1,952 |
1,542 |
$46K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,281 |
1,106 |
$37K |
| 81001 |
|
2,781 |
2,488 |
$37K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
454 |
380 |
$32K |
| 36415 |
Collection of venous blood by venipuncture |
4,237 |
3,416 |
$28K |
| 83690 |
|
1,500 |
1,333 |
$25K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
740 |
656 |
$24K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
27 |
25 |
$22K |
| 83880 |
|
407 |
299 |
$17K |
| 82150 |
|
604 |
538 |
$15K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
344 |
302 |
$15K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
557 |
501 |
$15K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
411 |
373 |
$14K |
| 71250 |
|
46 |
43 |
$12K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
298 |
260 |
$12K |
| 83605 |
|
666 |
524 |
$11K |
| J2704 |
Injection, propofol, 10 mg |
1,710 |
1,405 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
467 |
429 |
$9K |
| 85379 |
|
273 |
242 |
$8K |
| 87040 |
|
539 |
260 |
$7K |
| 80076 |
|
109 |
103 |
$7K |
| 80047 |
|
206 |
195 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
409 |
334 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
675 |
608 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
420 |
299 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
148 |
136 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
962 |
760 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,342 |
1,040 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
174 |
144 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,070 |
892 |
$3K |
| 85730 |
|
189 |
134 |
$3K |
| 85610 |
|
556 |
388 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
61 |
54 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16 |
12 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
75 |
68 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
60 |
57 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
597 |
518 |
$2K |
| 88304 |
|
43 |
36 |
$2K |
| 85027 |
|
206 |
166 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
13 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
74 |
67 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
177 |
152 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
142 |
118 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
657 |
522 |
$957.21 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
46 |
30 |
$747.14 |
| C1889 |
Implantable/insertable device, not otherwise classified |
43 |
42 |
$742.24 |
| J3490 |
Unclassified drugs |
1,885 |
926 |
$737.70 |
| 80061 |
Lipid panel |
60 |
53 |
$714.90 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
123 |
101 |
$656.79 |
| 84439 |
|
13 |
13 |
$534.88 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
32 |
31 |
$498.75 |
| 84703 |
|
34 |
28 |
$332.88 |
| 71046 |
Radiologic examination, chest; 2 views |
15 |
14 |
$328.89 |
| 73030 |
|
15 |
13 |
$282.95 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
222 |
192 |
$259.37 |
| 87077 |
|
14 |
14 |
$184.46 |
| 82550 |
|
16 |
13 |
$138.16 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
14 |
$129.36 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
78 |
68 |
$116.90 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
14 |
12 |
$42.56 |
| J7050 |
Infusion, normal saline solution, 250 cc |
28 |
24 |
$37.08 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
18 |
16 |
$2.80 |